Zhongshan Hospital Affiliated to Fudan University
Shanghai, Shanghai, China
Hospital in Shanghai
180 Fenglin Rd, Xuhui District, Shanghai, 200031
About Zhongshan Hospital Affiliated to Fudan University
Zhongshan Hospital, formerly Chung Shan Memorial Hospital, is a major teaching hospital in Shanghai, China, affiliated with the Shanghai Medical College of Fudan University.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shanghai Zhongshan Hospital
18
BeiGene
9
Fudan University
5
Pfizer
3
Second Affiliated Hospital, School of Medicine, Zhejiang University
3
Changhai Hospital
2
Hangzhou Endonom Medtech Co., Ltd.
2
Innovent Biologics (Suzhou) Co. Ltd.
2
Jiangsu HengRui Medicine Co., Ltd.
2
RemeGen Co., Ltd.
2
Shanghai PerHum Therapeutics Co., Ltd.
2
Clinical Trials at Zhongshan Hospital Affiliated to Fudan University
During the past decade, Zhongshan Hospital Affiliated to Fudan University conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 3 clinical trials were completed, i.e. on
average, 4% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 1 clinical trials were completed. i.e. 2.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension
2007-01-01
2007-11-01
Completed
1,134
The Protocol of Enhanced Recovery After Surgery in Colorectal Surgery
2006-09-01
2010-03-01
Unknown status
500
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2009-09-01
2016-01-01
Completed
347
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
2010-12-01
2011-10-01
Unknown status
332
Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD
2009-07-01
2012-12-01
Unknown status
460
A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients
2012-09-29
2020-01-08
Completed
207
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Zhongshan Hospital Affiliated to Fudan University" #1 sponsor was "Shanghai Zhongshan Hospital" with 18 trials, followed by "BeiGene" with 9 trials
sponsored, "Fudan University" with 5 trials sponsored, "Pfizer" with 3 trials sponsored and "Second Affiliated Hospital, School of Medicine, Zhejiang University"
with 3 trials sponsored. Other sponsors include 47 different institutions and
companies that sponsored additional 48 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Zhongshan Hospital Affiliated to Fudan University"
#1 collaborator was "Shanghai Zhongshan Hospital" with 13 trials as a collaborator, "Anhui Provincial Hospital" with 5 trials as a collaborator, "Ruijin Hospital" with 5 trials as a collaborator, "Changhai Hospital" with 3 trials as a collaborator and "Fudan University" with 3 trials as a collaborator. Other collaborators include 130 different institutions and companies that were
collaborators in the rest 108 trials.
Clinical Trials Conditions at Zhongshan Hospital Affiliated to Fudan University
According to Clinical.Site data, the most researched conditions in "Zhongshan Hospital Affiliated to Fudan University" are
"Hepatocellular Carcinoma" (5 trials), "Gastric Adenocarcinoma" (3 trials), "Advanced Solid Tumors" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Zhongshan Hospital Affiliated to Fudan University" in a lesser frequency.
Clinical Trials Intervention Types at Zhongshan Hospital Affiliated to Fudan University
Most popular intervention types in "Zhongshan Hospital Affiliated to Fudan University" are "Drug" (63 trials), "Procedure" (16 trials), "Device" (9 trials), "Biological" (7 trials) and "Other" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Tislelizumab" (9 trials), "Cisplatin" (5 trials), "Docetaxel" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Zhongshan Hospital Affiliated to Fudan University
The vast majority of trials in "Zhongshan Hospital Affiliated to Fudan University" are
89 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Zhongshan Hospital Affiliated to Fudan University
Currently, there are 48 active trials in "Zhongshan Hospital Affiliated to Fudan University".
3 are not yet recruiting,
34 are recruiting,
7 are Active, not recruiting,
and 4 are Enrolling by invitation.
In total, there were 15 completed trials in Zhongshan Hospital Affiliated to Fudan University,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Zhongshan Hospital Affiliated to Fudan University, 14 "Phase 1"
clinical trials were conducted, 29 "Phase 2" clinical
trials and 29 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 18 trials that are defined as “Not Applicable".